Ligand Pharmaceuticals Inc
LGND
Revenue
115.46M
▲67.83M▲142.43%
3 Months ChangeAssets
1.48B
▲528.17M▲55.68%
3 Months ChangeLiabilities
526.60M
▲406.53M▲338.56%
3 Months ChangeFree Cash Flow
-25.66M
▼-44.29M▼-237.75%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-07
Form 10-Q
ID: 0000886163-24-000071
2024-08-06
Form 8-K
ID: 0000886163-24-000067
2024-08-02
Form 8-K
ID: 0000886163-24-000064
2024-07-17
Form 8-K
ID: 0000886163-24-000061
2024-07-10
Form 8-K
ID: 0000886163-24-000059
2024-07-08
Form 8-K
ID: 0000886163-24-000053
2024-06-27
Form 8-K
ID: 0000886163-24-000051
2024-06-18
Form 8-K
ID: 0000886163-24-000047
2024-06-17
Form 8-K
ID: 0000886163-24-000045
2024-05-30
Form 8-K
ID: 0000886163-24-000039